Key developments in Australia’s medical technology sector reveal growing concern over Labor’s recent budget changes, particularly a 10-year limit on refundable R&D tax incentives. Health startups, which often require longer to bring products to market, fear these changes create a “triple threat” to their viability. Nine industry bodies, including Bio NSW and AusBiotech, have urged Treasurer Jim Chalmers to recalibrate these changes to support the sector’s success. The shifts in tax policy include alterations to the capital gains tax that may further discourage investment in R&D. Opposition parties have criticized these moves, warning they undermine innovation in Australia’s health technology landscape.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.abc.net.au/news/2026-06-06/medical-tech-sector-raises-fresh-concerns-labor-tax-cgt/106764464
